Biotech News

Anaptys Announces Participation in Upcoming Investor Conferences

AnaptysBio, Inc. (ANAB)AnaptysBio, Inc.Company update

SAN DIEGO, Nov. 10, 2026 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a company focused on managing the financial collaborations for Jemperli with Tesaro, a GSK company, and Quimilza (imsidolimab) with Vanda, today announced that members of its executive team are scheduled to participate in

Related news

AnaptysBio, Inc.

Biopharma Royalty Company Following the spin-off of First Tracks Biotherapeutics, AnaptysBio manages financial collaborations rather than operating an internal drug-development portfolio. Jemperli Economics Anaptys receives royalties tied to GSK’s Jemperli franchise, including development in endometrial, rectal, colon, and head and neck...

Recent company news

Stock data

Close
47.40 USD
Market cap
1.49B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States